Mark Sorin
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Logan A. Walsh (5 shared papers)Jonathan Spicer (5 shared papers)Jasmyn E. A. Cunningham (1 shared paper)Connor Prosty (4 shared papers)J. Adam Carter (1 shared paper)Kayla Williams (1 shared paper)Rahul Suresh (1 shared paper)Jérémie Richard (1 shared paper)
- Journals
- Clinical Infectious Diseases (1 paper)BMJ Open (1 paper)Clinical Microbiology and Infection (1 paper)Nature Communications (1 paper)ESMO Open (1 paper)
- Partner nations
- CanadaUnited StatesSpain
In The Last Decade
Mark Sorin
17 papers receiving 235 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 95
- Immunology 54
- Speech and Hearing 13
- Pulmonary and Respiratory Medicine 61
- Applied Psychology 7
Countries citing papers authored by Mark Sorin
This map shows the geographic impact of Mark Sorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sorin more than expected).
Fields of papers citing papers by Mark Sorin
This network shows the impact of papers produced by Mark Sorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sorin. The network helps show where Mark Sorin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Sorin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant Chemoimmunotherapy for NSCLC Hit paper breakdown → | 2024 | 89 |
| 2 | 2022 | 55 | |
| 3 | 2023 | 33 | |
| 4 | 2021 | 10 | |
| 5 | 2025 | 9 | |
| 6 | 2023 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2019 | 6 | |
| 9 | 2020 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2019 | 4 | |
| 12 | 2023 | 2 | |
| 13 | 2021 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2023 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2024 | 0 |
About Mark Sorin
Mark Sorin is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Physiology, Immunology and Infectious Diseases, having authored 19 papers that have together received 237 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (3 papers), Immune cells in cancer (3 papers), Lung Cancer Research Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lung Cancer Treatments and Mutations (2 papers), Immunotherapy and Immune Responses (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper) and Breast Cancer Treatment Studies (1 paper). The work is most often cited by research in Oncology (95 citations), Immunology (54 citations), Speech and Hearing (13 citations), Pulmonary and Respiratory Medicine (61 citations) and Applied Psychology (7 citations). Mark Sorin has collaborated with scholars based in Canada, United States and Spain. Frequent co-authors include Logan A. Walsh, Jonathan Spicer, Jasmyn E. A. Cunningham, Connor Prosty, J. Adam Carter, Kayla Williams, Rahul Suresh, Jérémie Richard, Pierre Fiset and Trafford Crump. Their work appears in journals such as Clinical Infectious Diseases, BMJ Open, Clinical Microbiology and Infection, Nature Communications and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.